---
title: Our Pipeline of Innovative Therapeutic Products | Orchestra BioMed
description: Our pipeline is comprised of innovative therapeutic products with the potential for optimized value creation using our partnership-enabled business model.
---

[![OBM_Logo_Orange_White_RGB-4](https://7401945.hs-sites.com/hubfs/OBM_Logo_Orange_White_RGB-4.png) ](https://7401945.hs-sites.com/)

**

**

Close

Our Innovations

## Pipeline

# Advancing a multi-asset pipeline of high-impact therapeutic solutions

Our pipeline is comprised of innovative therapeutic product candidates we believe have the potential for value creation using our partnership-enabled business model.

SWIPE TO SCROLL ![swipe to scroll](https://7401945.hs-sites.com/hubfs/scroll.png)

![Pipeline Chart](https://7401945.hs-sites.com/hubfs/05818_OBM_PipelineGraphic_L9.jpg) <https://7401945.hs-sites.com/backbeat-cnt> <https://7401945.hs-sites.com/virtue-sab>

Our flagship product candidates, BackBeat CNT (AVIM therapy) and Virtue SAB, exemplify key criteria that characterize innovations optimized for strategic partnerships:

- Target mature therapeutic device markets with significant unmet needs
- Provide high impact procedure-based solutions with rapid adoption potential
- Offer strategic and financial benefits to a commercial partner and Orchestra BioMed

*Plan to leverage existing coronary in-stent restenosis (ISR) data to support potential Pivotal Study; Virtue SAB has received Breakthrough Device Designation for: 1The balloon dilatation of the stenotic portion (up to 26 mm length) of a stented coronary artery that is 2.25 to 4.0 mm in diameter, for the purpose of improving lumen diameter; 2The balloon dilation of the de novo stenotic portion (up to 26mm in lesion length) of a native coronary artery of 2.0 mm to 2.5 mm in diameter (small coronary arteries), for the purpose of improving lumen diameter; 3The balloon dilatation of the stenotic portion (up to 18 mm length) of an infrapopliteal artery (P-3 segment or distal, below the knee, with reference vessel diameter (RVD) 2.25 - 4.0 mm), for the purpose of improving lumen diameter.

Virtue® SAB is investigational and not commercially approved.

BackBeat CNT™ (also known as AVIM therapy) is investigational and not commercially approved.

[![Orchestra BioMed logo](https://7401945.hs-sites.com/hs-fs/hubfs/OBM_Logo_Orange_White_RGB.png?width=260&name=OBM_Logo_Orange_White_RGB.png) ](https://7401945.hs-sites.com/)

[**](https://twitter.com/orchestrabiomed) [**](https://www.linkedin.com/company/orchestra-biomed/)

---

 © 2026 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.  
 All other trademarks are trademarks of their respective owners.  
 SM-0020 Rev 01

[Disclaimer](https://7401945.hs-sites.com/disclaimer)